Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Hoogtepunten van de 5e European Stroke Organisation Conference
jun 2019 | Neuro-vasculair